Source: Annual Congress 2006 - Exercise
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
T. Kutsuzawa, D. Kurita, M. Haida, S. Shioya (Isehara, Japan). Effects of long-term supplementation of branched-chain amino acids on muscle metabolism in COPD patients. Eur Respir J 2006; 28: Suppl. 50, 3727

Member's Comments

No comment yet.

Related content which might interest you: Muscle energy metabolism and plasma amino acids level in patients with chronic respiratory impairment Source: Eur Respir J 2002; 20: Suppl. 38, 289s Year: 2002 Does a supplementation in branch amino acid improve pulmonary rehabilitation effect in COPD? Source: Virtual Congress 2021 – A multidisciplinary approach to pulmonary rehabilitation and management of chronic respiratory diseases Year: 2021 Glucocorticoids correct fatty acids composition in asthma patients. Composition of fatty acids in high density lipoproteins in bronchitis patients Source: Eur Respir J 2007; 30: Suppl. 51, 145s Year: 2007 Oral polyunsaturated fatty acid supplementation as adjuvant therapy for asthmatic children Source: Annual Congress 2012 - Asthma treatment: efficacy and safety Year: 2012 Amino acids and asthma: a case-control study Source: Eur Respir J 2004; 23: 565-568 Year: 2004 Dietary supplementation over one year with fatty acids reduces inflammatory markers and produces clinical improvement in adults with cystic fibrosis Source: Annual Congress 2007 - Cystic fibrosis lung disease: what do we measure? What do we know? Year: 2007 Effect of omega-3 and phosphoethanolamine in patients with asthma Source: Annual Congress 2009 - Towards improving asthma control Year: 2009 Effectiveness of omega-3 polyunsaturated fatty acids in combination with acetylsalicylic acid in patients with COPD, complicated by cor pulmonale and the syndrome of blood hypercoagulation Source: Eur Respir J 2004; 24: Suppl. 48, 59s Year: 2004 The effect of dietary fatty acids on respiratory infection in human lung cells Source: International Congress 2018 – Disease exacerbations from a molecular point of view Year: 2018 Supplementation with n-3 fatty acids and markers of oxidative stress in elderly exposed to PM2.5 Source: Eur Respir J 2007; 30: Suppl. 51, 630s Year: 2007 Effects of n-3 polyunsaturated fatty acids on inflammatory markers in chronic obstructive pulmonary disease Source: Eur Respir J 2006; 28: Suppl. 50, 39s Year: 2006 Plasma amino acid profiles in patients of various respiratory disorders Source: Annual Congress 2010 - From rare towards common lung diseases: diagnostic and monitoring challenges Year: 2010 The effect of conjugated linoleic acid supplementation on the nutritional status of COPD patients Source: International Congress 2016 – Novel avenues in the treatment of COPD II Year: 2016 The effects of conjugated linoleic acid supplementation on the serum levels of Interleukin-6 and Sirtuin-1 in COPD patients Source: International Congress 2019 – Basic research of airway diseases Year: 2019 Is adult asthma/chronic bronchitis related to the intake of fat especially polyunsaturated ω-6 and ω-3 fatty acids? Source: Eur Respir J 2001; 18: Suppl. 33, 199s Year: 2001 Supplementation with polyunsaturated fatty acids influence the inflammatory response and airway nitric oxide in patients with cystic fibrosis Source: Annual Congress 2008 - Cystic fibrosis: novel aspects of airway function and inflammation Year: 2008 The role of free fatty acids in idiopathic pulmonary fibrosis Source: International Congress 2017 – From idiopathic pulmonary fibrosis (IPF) to rare diseases Year: 2017 The effect of dietary fatty acids on inflammation in primary lung mesenchymal cells Source: International Congress 2018 – COPD: immune regulation and therapeutic targets Year: 2018 The role of partially hydrolysed formulae, probiotics and omega-3 fatty acids in cow‘s milk allergy in children Source: Annual Congress 2009 - Clinical advances in childhood asthma Year: 2009 Increased fatty acid oxidation impairs myoblast differentiation in hypercapnia Source: International Congress 2017 – Novel molecular and genetic targets in COPD Year: 2017